Current issues of ACP Journal Club are published in Annals of Internal Medicine


Correction

Correction - Glycoprotein IIb/IIIa-receptor antagonists reduce combined death or MI in patients with ischemic heart disease

ACP J Club. 1999 Sep-Oct;131:A16 doi:10.7326/ACPJC-1999-131-2-A16

Related Content in the Archives
• Corrected Abstract or Commentary: Review: Glycoprotein IIb/IIIa-receptor antagonists reduce combined death or MI in patients with ischemic heart disease



The title of a recent abstract (1) was worded incorrectly. Glycoprotein IIb/IIIa-receptor antagonists reduce combined death or MI in patients with ischemic heart disease, not glycoprotein IIa/IIIb-receptor antagonists, as originally stated.


References

1. Review: Glycoprotein IIb/IIIa-receptor antagonists reduce combined death or MI in patients with ischemic heart disease [Abstract]. ACP Journal Club. 1999 July-Aug;131:4. Abstract of: Kong DF, Califf RM, Miller DP, et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation. 1998 Dec 22/29;98:2829-35.